Aryl Hydrocarbon Receptor Repressor Methylation: A Link Between Smoking and Atherosclerosis.
From the Department of Neurology, Maryland Stroke Center, University of Maryland School of Medicine, Baltimore (J.W.C.); Department of Neurology, Baltimore VA Medical Center, Baltimore (J.W.C.); and Division of Endocrinology, Department of Medicine, University of Maryland School of Medicine, Baltimore (H.X.). jcole@som.umaryland.edu.
John W
JW
Cole
From the Department of Neurology, Maryland Stroke Center, University of Maryland School of Medicine, Baltimore (J.W.C.); Department of Neurology, Baltimore VA Medical Center, Baltimore (J.W.C.); and Division of Endocrinology, Department of Medicine, University of Maryland School of Medicine, Baltimore (H.X.).
Huichun
H
Xu
D050197:Atherosclerosis / Q000378:metabolism*; D051792:Basic Helix-Loop-Helix Proteins / Q000235:genetics*; D019175:DNA Methylation; D005260:Female; D006801:Humans; D008297:Male; D018336:Receptors, Aryl Hydrocarbon / Q000378:metabolism*; D012097:Repressor Proteins / Q000235:genetics*; D012907:Smoking
D051792:Basic Helix-Loop-Helix Proteins; D018336:Receptors, Aryl Hydrocarbon; D012097:Repressor Proteins
Editorials; aryl-hydrocarbon receptor repressor protein, human; atherosclerosis; epigenenomics; methylation; smoking